LNSR Stock Analysis: Buy, Sell, or Hold?
LNSR - LENSAR, Inc. Common Stock
$6.19
-0.22 (-3.36%)
▼
5d:
+9.86%
30d:
+7.75%
90d:
+2.06%
BUY
MODERATE Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 06, 2026
30d
Get Alerted When LNSR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LNSR shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: LNSR shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LNSR is currently trading at $6.18, which is considered extended relative to its 30-day fair value range of $5.61 to $6.06. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.0) compared to its historical average (14.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNSR is in a strong downtrend. The price is approaching resistance at $6.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: LNSR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+32.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNSR is in a strong downtrend. The price is approaching resistance at $6.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: LNSR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+32.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.61 -
$6.06
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 32.8% below Wall St target ($8.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$5.61 -
$6.06
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.50
Resistance Level
$6.11
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.01
Wall Street Target
$8.50
(+32.8%)
Revenue Growth (YoY)
-5.2%
Profit Margin
50.9%
PE vs Historical
-9.0 vs 14.6
CHEAP
Share & Embed Analysis
Last updated: July 06, 2026 3:33 PM ET
Data refreshes hourly during market hours. Next update: 4:33 PM
Data refreshes hourly during market hours. Next update: 4:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNSR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 60 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 57 HOLD |
